{"id":"NCT00393523","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)","officialTitle":"A Study to Assess the Anamnestic Immune Response 4 to 8 Years After a Primary Vaccination Series With HBVAXPRO","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-09","primaryCompletion":"2008-06","completion":"2008-06","firstPosted":"2006-10-27","resultsPosted":"2009-10-12","lastUpdate":"2017-04-12"},"enrollment":1478,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Hepatitis B"],"interventions":[{"type":"BIOLOGICAL","name":"Comparator: Modified Process Hepatitis B Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: Comparator: ENGERIX-B","otherNames":[]}],"arms":[{"label":"5 µg Modified Process Hepatitis B Vaccine Booster (Group 1)","type":"ACTIVE_COMPARATOR"},{"label":"10 µg ENGERIX-B™ Booster (Group 2)","type":"ACTIVE_COMPARATOR"},{"label":"5 µg Modified Process Hepatitis B Vaccine Booster (Group 3)","type":"ACTIVE_COMPARATOR"},{"label":"10 µg ENGERIX-B™ Booster (Group 4)","type":"ACTIVE_COMPARATOR"},{"label":"5 µg Modified Process Hepatitis B Vaccine (Group 5)","type":"EXPERIMENTAL"}],"summary":"To assess the safety and immunogenicity of a booster dose of hepatitis B vaccine in children who have received a 3-dose primary series of either RECOMBIVAX HB or ENGERIX-B. The primary vaccination series (was given 4 to 8 years prior to study entry and consisted of a licensed hepatitis B vaccine product (either RECOMBIVAX HB or ENGERIX-B). The booster dose given in this study will be either an investigational Merck product (Modified Process Hepatitis B Vaccine) or licensed ENGERIX-B vaccine.","primaryOutcome":{"measure":"Antibody Response to Hepatitis B Surface Antigen in Subjects Who Received a 3-dose Primary Series of RECOMBIVAX HB in Infancy","timeFrame":"4 weeks after vaccination with either modified process hepatitis B vaccine or ENGERIX-B","effectByArm":[{"arm":"Modified Process Hepatitis B Vaccine Booster (Group 1)","deltaMin":323,"sd":null},{"arm":"ENGERIX-B™ Booster (RECOMBIVAX-HB™ in Infancy) (Group 2)","deltaMin":305,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.001"},{"comp":"OG000","p":"<0.001"},{"comp":"OG001","p":"0.19"}]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20724955"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":369},"commonTop":["Pain, Injection site for hepatitis B vaccine","Swelling, Injection site for hepatitis B vaccine","Erythema, Injection site for hepatitis B vaccine","Pyrexia","Headache"]}}